Currently on the Patient Engagement Pavilion stage is the @ADAPTABLEstudy participants speaking on being active in research projects. #ACC18

ASA 325mg is not superior to 81mg Most important message is to patients #ADAPTABLEstudy #ACC21 @TKDsosyal @cerol191 @Sema_Guneri @ozcan__basaran @kardiyobey @drpablocorral @umityasarsinan1 @LaleTokgozoglu @mdlaledinc @EvrimSimsek2 @gokselcinier @leventcanh

The @ADAPTABLEstudy helps to embed patients in the clinical research process. #acc18

Spotlight poster #ICPE2019; Health Plan recruitment into @ADAPTABLEstudy a pragmatic study in @PCORnetwork encore posters available on computable phenotype validation and outcome ascertainment

Great presentation from @AusTXTucker and @hrhrobertson on the @ADAPTABLEstudy today at #dpharm2019

#adaptablestudy success comes from having a great team! @PCORI @robmentz @MTRHeart @H_eHA @Intermountain @KirkKnowlton @RealCruzHenry @schuyler_jones @DrBenjaminHorne @ADAPTABLEstudy #research #science #pragmatictrials

Poster #24: Improving Retention with Clinician & Patient Engagement: Lessons from the @ADAPTABLEstudy @DCRINews @VanderbiltU @H_eHA @NorthwesternMed @REACHnetCDRN @KUnews #PCORI2018 @PCORI

#PCORnet powered #ADAPTABLEstudy provides an inspiring new #clinicalresearch paradigm. Read: https://t.co/Z9LLwmFDDx

Greasy summary of the #LBCT from #ACC21 today Interesting to have 3 Negative trials on Day 1! ❌ADAPTABLE @ADAPTABLEstudy ❌PARADISE-MI ❌ATLANTIS ❇️LAAOS ❇️EXPLORER HCM Kind of cool to not have the expected- only positive trials often get the headlines!

Poster #25: Role of Health Plan Administrative Claims Data in Participant Recruitment for Pragmatic Clinical Trial - An @ADAPTABLEstudy Example #PCORI2018 @PCORI @khaynes001 @DCRINews

Exciting to hear @schuyler_jones describing @ADAPTABLEstudy pragmatic trial using computable phenotypes, outreach through EHR, and participants able to provide consent online & self-randomize @DukeMedSchool #GrandRounds

Unprecendented speed of enrolment using computable phenotype for recruitment at @MayoClinic in the @ADAPTABLEstudy #AHA18 @schuyler_jones @MTRHeart @Ajar_Kochar @a_sharlow @hrhrobertson

Which is the correct daily dose for high-risk heart patients? Low-dose 81mg aspirin or higher-dose 325mg? No difference in effectiveness, so why take the higher dose - w. potential >bleeding risk? #ADAPTABLEstudy #ACC21

ICYMI: #PCORnet powered #ADAPTABLEstudy provides an inspiring new #clinicalresearch paradigm. Read: https://t.co/Z9LLwmXev5

1st enrolled at @IntermtnMedCtr!!! #ADAPTABLEstudy #pragmatictrials @PCORI @DCRINews @texhern @MTRHeart @schuyler_jones @califf001 @KirkKnowlton @HeartBobH https://t.co/HCzrW5TEVZ #research #science

Feeling relieved to see the high-level @ADAPTABLEstudy results at #ACC21. Glad to know that my recommendation for patients to use ASA 81mg hold up to what I was taught by Dr Bates at @umichCVC . Kudos to @schuyler_jones and colleagues!

The @ADAPTABLEstudy team, led by PI @schuyler_jones, has been honored with a 2022 Top 10 Clinical Research Achievement Award from @CRForumUS. Read more: https://t.co/6L8PmoRKRK @PCORI @PCORnetwork @texhern

Happy to introduce Heart Trials, in time for #ACC21! Our first guests, @schuyler_jones of @ADAPTABLEstudy and @manesh_patelMD of @DukeHeartCenter, discussed the new trial's contribution to #aspirin dosing. LISTEN HERE: https://t.co/w7MoY0QwQG

How did DCRI design the @ADAPTABLEstudy, the landmark pragmatic trial to determine the right dose of aspirin for people with #heartdisease? Read a Q&A with DCRI Executive Director @texhern: https://t.co/W3OyVkedrc @PCORnetwork @PCORI #EHRs